Brainomix Company
Brainomix has developed automated medical software for stroke image analysis, and lung diseases such as NSCLC and IPF. Our Radiology AI biomarkers enable precision medicine for better treatment.
Investors
%20.jpg)
Founded Date:
2010-01-01
Last Funding Type:
Series B
Headquarters:
Oxford, Oxfordshire, United Kingdom
Investors Number:
6
Employee Number:
9
Industry:
Aging Biomarkers
Estimated Revenue:
$33.16M
Last Funding Date:
2021-12-16
Number Of Exists:
11-50
Funding Status:
Early Stage Venture
Total Funding:
35017490